Olaf Klungel

10PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmacogenomicsCardiology (incl. cardiovascular diseases)Pharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 07, 2026
Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use.

Nicholas B Hunt, Patrick Souverein, Marloes Bazelier

|Aug 19, 2024
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.

Ditte B Iversen, Ann-Cathrine Dalgård Dunvald, Martin Thomsen Ernst

|Jul 27, 2022
Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study.

Mirjam Hempenius, Simone Rijken, Rolf H H Groenwold

|Mar 10, 2022
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.

Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse

|Aug 16, 2021
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact.

Mirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer

|Feb 05, 2021
Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants.

Mirjam Hempenius, Rolf H H Groenwold, Patrick C Souverein

Pageof 2